Invention Grant
- Patent Title: Gene therapy methods
-
Application No.: US15728381Application Date: 2017-10-09
-
Publication No.: US10280435B2Publication Date: 2019-05-07
- Inventor: Olivier Negre , Emmanuel Payen , Philippe Leboulch , Yves Beuzard
- Applicant: bluebird bio, Inc.
- Applicant Address: US MA Cambridge
- Assignee: bluebird bio, Inc.
- Current Assignee: bluebird bio, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Main IPC: C12N15/85
- IPC: C12N15/85 ; A61K35/28 ; A61K35/18 ; A61K38/18 ; A61K48/00 ; C07K14/71 ; C07K14/805 ; C12N15/86 ; A61K35/12
Abstract:
The present invention generally provides improved gene therapy vectors, cell-based compositions, and methods of using the same in methods of gene therapy. The present invention further provides improved gene therapy compositions for expanding hematopoietic cells and related methods for treatment of diseases, disorders, and conditions of the hematopoietic system such as thalassemias and anemias.
Public/Granted literature
- US20180201952A1 GENE THERAPY METHODS Public/Granted day:2018-07-19
Information query
IPC分类:
